YIH
CMD

Y-Intercept (HK)’s Cantel Medical Corporation CMD Stock Holding History

Y-Intercept (HK)’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-3,019
Closed -$238K – 888
2020
Q4 		$238K Buy
+3,019
New +$177K 0.1% 396

Other funds holding CMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
LGP
Leonard Green & Partners Los Angeles, California $2.77B AUM 3.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Y-Intercept (HK)'s CMD Position: Q1 2021 in Review

Y-Intercept (HK) sold out of Cantel Medical Corporation (CMD) in Q1 2021, closing a stake of 3,019 shares — an estimated $238K sold.

Y-Intercept (HK) first reported a position in CMD in Q4 2020 and held it in 1 quarter. The position peaked at $238K in Q4 2020. 234 funds tracked by Wall St. Rank hold CMD as of Q1 2021.

  • Y-Intercept (HK) reported no remaining Cantel Medical Corporation position as of Q1 2021 after selling out during the quarter.
  • Y-Intercept (HK) sold 3,019 Cantel Medical Corporation shares in Q1 2021, an estimated $238K.
  • Y-Intercept (HK) first reported a position in Cantel Medical Corporation in Q4 2020 and held it in 1 quarter.
  • Y-Intercept (HK)'s Cantel Medical Corporation position peaked at $238K in Q4 2020.
  • 234 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q1 2021.

Based on Y-Intercept (HK)'s 13F filing for Q1 2021, filed 12 May 2021.